Home
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

Today’s Highlights December 18, 2025

BioNTech in the NEWS
MAINZ, Germany, December 18, 2025 – BioNTech SE (BNTX) announced the closing of its acquisition of CureVac N.V. (This content is for paid subscribers.

Please click here to subscribe or here to log in.
Today’s Highlights
,
December 18, 2025

Other Articles